CLINICAL_TRIALS
research
· 2026-01-14
Clinical Trial Update: Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI) [NA]
Summary
A clinical trial evaluating whether ulinastatin and thymosin α1 can mitigate immune dysregulation and organ dysfunction after acute aortic dissection surgery; c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nanjing Medical University | Conditions: Aortic Dissection, Aortic Dissection Aneurysm | NA | Status: ENROLLING_BY_INVITATION